#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Conjunctivitis allergic Endometrial cancer recurrent Indolent systemic mastocytosis Myxoid liposarcoma Hypertriglyceridaemia Lymphoma Loeys-Dietz syndrome Pleomorphic leiomyosarcoma Retinoblastoma Angiosarcoma Loss of consciousness Hypergammaglobulinaemia benign monoclonal Retinal dystrophy Pseudomyxoma peritonei Transitional cell cancer of the renal pelvis and ureter More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Life with Disease Immunodeficiency congenital – Treatment SAPHO syndrome – Basic Information Angiosarcoma – Diagnostics Brain stem glioma – Life with Disease Wiskott-Aldrich syndrome – Basic Information Pulmonary fibrosis – Treatment Sjogren’s syndrome – Basic Information Myxofibrosarcoma – Diagnostics Pelizaeus-Merzbacher disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefuroxime Sodium Betamethasone Valerate Metoprolol Succinate Cusatuzumab Nicotinamide Bp Benzalkonium Chloride GSKVX000000030825 Perflutren Avibactam Sodium Alglucosidase Alfa Nnc0194-0499 Olopatadine Mercaptamine Alfacalcidol Lysine Aspirin Tebipenem Pivoxil Hydrobromide Urea Thiamine Nitrate Sulodexide Pasireotide More therapies…

    Learn about Your Condition

    Ear discomfort Shprintzen-Goldberg syndrome Vascular calcification Osteosarcoma recurrent Cystic fibrosis Demyelination Septic shock High-grade B-cell lymphoma Anal squamous cell carcinoma Childhood asthma Erythema multiforme Propionic acidaemia Abdominal wall pain Lymphocyte adoptive therapy Toxicity to various agents More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Using Nicotine Electronic Cigarettes and Varenicline for Smoking Cessation in Smokers of 10+ Cigarettes Daily

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Varenicline
    France

  • Study of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Tipiracil Hydrochloride
    • Trifluridine
    Germany Spain

  • Study on Gene Therapy for Patients with RAG1-Deficient Severe Combined Immunodeficiency Using RAG1-LV-CD34+ Cells

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Autologous haematopoietic stem cell transplant
    Italy The Netherlands Poland Spain

  • Study on the Safety and Effectiveness of Peginterferon Alfa-2a and Ruxolitinib for Newly Diagnosed Polycythemia Vera Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Peginterferon Alfa-2A
    • Ruxolitinib
    Denmark

  • Study on the Treatment of Warthin’s Tumor with Bleomycin Sclerotherapy for Patients with Warthin’s Tumor

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Papillary cystadenoma lymphomatosum
    Investigated Drugs:
    • Bleomycin Sulfate Ph. Eur.
    Finland

  • Study on the Effects of Colchicine on Blood Vessel Function in Patients with Chronic Heart Failure and CHIP Mutations

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Colchicine
    Germany
Previous Page
1 … 860 861 862 863 864 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!